معرفی
Professor Helen Rizos is a leading academic at Macquarie University, holding roles as Principle Investigator of the Macquarie University Cancer Biobank and Head of the Precision Cancer Therapy research team within the Macquarie School of Medicine, Faculty of Medicine, Health and Human Sciences. She completed her PhD at Macquarie University and has been an independent group leader since 2000. Her research focuses on melanoma biology, treatment resistance, and liquid biomarkers, with over 170 publications and 9,218 citations. She leads key initiatives like the ACRF Centre for Advanced Cancer Modelling (COMET) and has received prestigious awards, including the Jim Piper Award for Research Leadership (2023).
- Education:
- Bachelor of Science (Honors I) from University of New South Wales
- PhD from Macquarie University
- Research Themes:
- Liquid biomarkers for treatment resistance prediction
- Mechanisms of therapy resistance in melanoma
- Development of novel cancer models
- Affiliations:
- Faculty member, Melanoma Institute Australia
- Principal Investigator, Macquarie University Cancer Biobank
Her research has advanced understanding of ctDNA dynamics in melanoma prognosis, immunotherapy response, and targeted therapy resistance. Key projects include AI-driven cancer modeling (BioInnoMQ) and liquid biopsy applications for cancer care.
Awards:
- Jim Piper Award for Excellence in Research Leadership (2023)
- Wildfire Highly Cited Publication Award (2017)
Grants & Collaborations:
- ACRF Centre for Advanced Cancer Modelling (2024–2030)
- CRE-USYD Oral Cancer Excellence Centre (2024–2029)
Labs/Teams: Leads the Precision Cancer Therapy team and collaborates with institutions like Westmead Institute for Medical Research and Melanoma Institute Australia.
